CClinicalTrials.gg
Not yet recruitingNCT07385378Updated Feb 4, 2026

Effects of Myofascial Chain Tension Modulation Combined With Scapular Corrective Exercise on Scapular Movement Performance and Functional Outcomes in Tennis Players With Subacromial Impingement Syndrome

An interventional study of Instrument-Assisted Soft Tissue Mobilization and Elastic band in Subacromial Impingement Syndrome, sponsored by China Medical University Hospital. Not yet recruiting. Open to participants aged 20 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-04.

Sponsored by China Medical University Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
20 Years to 35 Years
Sex
All
01

Study summary

Subacromial Impingement Syndrome (SIS) is characterized by abnormal scapular motion, including decreased upward rotation, increased internal rotation, and excessive anterior tilting, which impair shoulder and arm function. Integrated scapular rehabilitation combines Instrument-Assisted Soft Tissue Mobilization (IASTM) and postural correction exercises. IASTM detects soft tissue restrictions through multidirectional strokes and enhances the pain threshold of myofascial trigger points (MTrPs) via reflex hyperemia. Postural correction exercises aim to strengthen weakened muscles and stretch tight ones to improve stability and posture. The combination of these interventions may enhance scapular stability and dynamic control. This study aimed to investigate the effects of integrated scapular rehabilitation on scapular kinematics, movement correction, functional improvement, and pain management in tennis athletes with SIS. A two-way repeated-measures ANOVA was used to analyze pre- and post-intervention effects.

Read the detailed description

Participants aged 20 years or older were recruited. Outcome measures included pain intensity, Shoulder Pain and Disability Index (SPADI), shoulder range of motion (flexion, abduction, internal and external rotation), modified Scapular Assistance Test (mSAT), muscle strength (upper, middle, and lower trapezius; serratus anterior; rhomboids; levator scapulae; internal and external rotators), soft tissue elasticity (upper trapezius), myofascial trigger point pain threshold (upper trapezius, pectoralis minor, levator scapulae, rhomboids), subacromial space, and supraspinatus thickness.

02

Conditions studied

  • Subacromial Impingement Syndrome

Keywords

  • muscle imbalance
  • scapular dyskinesis
  • instrument-assisted soft tissue mobilization
03

In context

Shoulder Impingement Syndrome

304 studies on the registry are indexed under Shoulder Impingement Syndrome; 55 are open to participants now.

This study's planned enrollment of 36 is below the median of 54 across 261 interventional studies indexed under Shoulder Impingement Syndrome.

Browse Shoulder Impingement Syndrome studies →

Lead sponsor

China Medical University Hospital is the lead sponsor of 464 studies on the registry; 116 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participants were included if they met all of the following conditions:

    1. a VAS score greater than 3 during the Hawkins test (indicating mild to moderate pain),
    2. at least two positive results among the Hawkins test, Neer test, and painful arch test, and
    3. a positive result on the mSAT. Only participants who fulfilled all three criteria were enrolled in the study.

Exclusion criteria

Exclusion Criteria:

  • Participants were excluded if they had a history of clavicle, scapular, or humeral fractures; shoulder dislocation; or rotator cuff surgery; positive results on the cervical compression test, apprehension test, or drop arm test; had received corticosteroid injections within the past three months; had undergone physical therapy within the past six months; or reported a VAS score higher than 9.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Integrated scapular rehabilitation training (Instrument-Assisted Soft Tissue Mobilization+ Exercise)

    The integrated scapular rehabilitation training group received a specially designed scapular core rehabilitation program, which included the use of IASTM to inhibit overactive and tight muscles, targeted stretching exercises, strengthening training for elongated or weakened muscles, and finally, movement integration through multi-joint exercises.

    Device: Instrument-Assisted Soft Tissue Mobilization · Device: Elastic band

  • Active comparator
    Conventional rehabilitation (Stretch+ Exercise)

    The conventional rehabilitation training group received only traditional rehabilitation exercises, including stretching and strengthening training.

    Device: Elastic band

Interventions

  • DeviceInstrument-Assisted Soft Tissue Mobilization

    IASTM is an assistive instrument designed to reduce the physical effort required by the practitioner and can be applied without a specific directional pattern. It aims to induce localized reactive hyperemia through repeated application, temporarily alter tissue rheological properties, and modulate sensory feedback via cutaneous mechanoreceptors. Its mechanisms involve both mechanical and neurophysiological components.

  • DeviceElastic band

    Elastic resistance bands of different colors were used for resistance training, with training intensity increased or decreased by selecting bands of varying resistance levels.

06

What researchers measure

Primary outcomes

  1. Pain (VAS score during the Hawkins test)

    Time frame: Participants were assessed at time points: prior to the intervention (baseline), immediately three weeks after the intervention, and at a one-month follow-up.

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07385378
Lead sponsor
China Medical University Hospital
Responsible party
Sponsor
First posted
Feb 4, 2026
Start date
Feb 1, 2026 (estimated)
Primary completion
Jul 31, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
Feb 4, 2026

Study contacts

Yueh-Ling Hsieh, PHD
Contact
sherrie@mail.cmu.edu.tw
04-22053366 ext. #7312
Yu-Wei Lee
Contact
will860619@gmail.com
0972141913

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion